165 related articles for article (PubMed ID: 31387885)
1. Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study.
Garrel R; Mazel M; Perriard F; Vinches M; Cayrefourcq L; Guigay J; Digue L; Aubry K; Alfonsi M; Delord JP; Lallemant B; Even C; Daurès JP; Landais P; Cupissol D; Alix-Panabières C
Clin Chem; 2019 Oct; 65(10):1267-1275. PubMed ID: 31387885
[TBL] [Abstract][Full Text] [Related]
2. Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study.
Mazard T; Cayrefourcq L; Perriard F; Senellart H; Linot B; de la Fouchardière C; Terrebonne E; François E; Obled S; Guimbaud R; Mineur L; Fonck M; Daurès JP; Ychou M; Assenat E; Alix-Panabières C
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34199250
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.
Ramirez JM; Fehm T; Orsini M; Cayrefourcq L; Maudelonde T; Pantel K; Alix-Panabières C
Clin Chem; 2014 Jan; 60(1):214-21. PubMed ID: 24255082
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck.
Tinhofer I; Konschak R; Stromberger C; Raguse JD; Dreyer JH; Jöhrens K; Keilholz U; Budach V
Ann Oncol; 2014 Oct; 25(10):2042-2047. PubMed ID: 25057171
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients.
Le Louedec F; Alix-Panabières C; Lafont T; Allal BC; Garrel R; Digue L; Guigay J; Cupissol D; Delord JP; Lallemant B; Alfonsi M; Aubry K; Mazel M; Becher F; Perriard F; Chatelut E; Thomas F
Br J Clin Pharmacol; 2019 Jun; 85(6):1357-1366. PubMed ID: 30811063
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance.
Grisanti S; Almici C; Consoli F; Buglione M; Verardi R; Bolzoni-Villaret A; Bianchetti A; Ciccarese C; Mangoni M; Ferrari L; Biti G; Marini M; Ferrari VD; Nicolai P; Magrini SM; Berruti A
PLoS One; 2014; 9(8):e103918. PubMed ID: 25105871
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC).
Papadaki MA; Messaritakis I; Fiste O; Souglakos J; Politaki E; Kotsakis A; Georgoulias V; Mavroudis D; Agelaki S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477700
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer.
Dirix L; Buys A; Oeyen S; Peeters D; Liègeois V; Prové A; Rondas D; Vervoort L; Mariën V; Laere SV; Vermeulen P
Breast Cancer Res Treat; 2022 Jun; 193(2):437-444. PubMed ID: 35397078
[TBL] [Abstract][Full Text] [Related]
9. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system.
Nichols AC; Lowes LE; Szeto CC; Basmaji J; Dhaliwal S; Chapeskie C; Todorovic B; Read N; Venkatesan V; Hammond A; Palma DA; Winquist E; Ernst S; Fung K; Franklin JH; Yoo J; Koropatnick J; Mymryk JS; Barrett JW; Allan AL
Head Neck; 2012 Oct; 34(10):1440-4. PubMed ID: 22076949
[TBL] [Abstract][Full Text] [Related]
11. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
12. Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Patients.
Yang B; Qin A; Zhang K; Ren H; Liu S; Liu X; Pan X; Yu G
Oncol Res; 2017 Nov; 25(9):1601-1606. PubMed ID: 28474575
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumour cells in metastatic head and neck cancers.
Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating tumor cells in breast cancer patients: prognostic predictive role.
Turker I; Uyeturk U; Sonmez OU; Oksuzoglu B; Helvaci K; Arslan UY; Budakoglu B; Alkis N; Aksoy S; Zengin N
Asian Pac J Cancer Prev; 2013; 14(3):1601-7. PubMed ID: 23679243
[TBL] [Abstract][Full Text] [Related]
15. Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes.
Morgan TM; Wang X; Qian X; Switchenko JM; Nie S; Patel KR; Cassidy RJ; Shin DM; Beitler JJ
Clin Transl Oncol; 2019 Mar; 21(3):342-347. PubMed ID: 30084036
[TBL] [Abstract][Full Text] [Related]
16. Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma.
Zhou S; Wang L; Zhang W; Liu F; Zhang Y; Jiang B; Wang J; Yuan H
Technol Cancer Res Treat; 2021; 20():1533033821990037. PubMed ID: 33641530
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
Basso U; Facchinetti A; Rossi E; Maruzzo M; Conteduca V; Aieta M; Massari F; Fraccon AP; Mucciarini C; Sava T; Santoni M; Pegoraro C; Durante E; Nicodemo M; Perin A; Bearz A; Gatti C; Fiduccia P; Diminutto A; Barile C; De Giorgi U; Zamarchi R; Zagonel V
Oncologist; 2021 Sep; 26(9):740-750. PubMed ID: 34077597
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cell abundance in head and neck squamous cell carcinoma decreases with successful chemoradiation and cetuximab treatment.
Poellmann MJ; Bu J; Kim D; Iida M; Hong H; Wang AZ; Wheeler DL; Kimple RJ; Hong S
Cancer Lett; 2023 May; 562():216187. PubMed ID: 37068555
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Wang Z; Cui K; Xue Y; Tong F; Li S
Med Oncol; 2015 May; 32(5):164. PubMed ID: 25895596
[TBL] [Abstract][Full Text] [Related]
20. The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.
Wang HM; Wu MH; Chang PH; Lin HC; Liao CD; Wu SM; Hung TM; Lin CY; Chang TC; Tzu-Tsen Y; Hsieh JC
Head Neck; 2019 Aug; 41(8):2676-2687. PubMed ID: 30903634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
